Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
7.26
+0.01 (0.14%)
Feb 4, 2026, 3:04 PM CST
SHE:002107 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 394.41 | 344.77 | 401.1 | 278.29 | 326.84 |
Cash & Short-Term Investments | 394.41 | 344.77 | 401.1 | 278.29 | 326.84 |
Cash Growth | 14.40% | -14.04% | 44.13% | -14.86% | -33.89% |
Accounts Receivable | 70.64 | 71 | 99.21 | 146.8 | 115.59 |
Other Receivables | 5.42 | 16.65 | 19.96 | 21.23 | 8.72 |
Receivables | 76.06 | 87.65 | 119.17 | 168.04 | 124.31 |
Inventory | 93.46 | 107.13 | 149.09 | 146.03 | 165.91 |
Other Current Assets | 2.84 | 3.56 | 3.65 | 6.84 | 3.5 |
Total Current Assets | 566.77 | 543.12 | 673 | 599.21 | 620.57 |
Property, Plant & Equipment | 326.45 | 355.46 | 382.98 | 409.78 | 447.75 |
Goodwill | 32.51 | 32.51 | 32.51 | 32.51 | 32.51 |
Other Intangible Assets | 34.34 | 35.56 | 36.84 | 36.03 | 54.8 |
Long-Term Deferred Tax Assets | 0.36 | 1.03 | 0.73 | 1.19 | 2.76 |
Other Long-Term Assets | 16.95 | 18.05 | 18.65 | 21.28 | 2.71 |
Total Assets | 977.37 | 985.73 | 1,145 | 1,100 | 1,161 |
Accounts Payable | 38.75 | 41.97 | 54.47 | 45.28 | 26.85 |
Accrued Expenses | 149.07 | 153.92 | 170.75 | 174.06 | 117.43 |
Short-Term Debt | - | - | - | 0.28 | - |
Current Portion of Leases | 0.92 | 1.02 | 0.4 | 0.73 | - |
Current Income Taxes Payable | 5.51 | 3.19 | 3.13 | 7.43 | 7.9 |
Current Unearned Revenue | 5.44 | 6.85 | 5.6 | 12.43 | 5.55 |
Other Current Liabilities | 41.04 | 35.34 | 53.64 | 43.24 | 46.01 |
Total Current Liabilities | 240.73 | 242.29 | 287.99 | 283.44 | 203.74 |
Long-Term Leases | 0.23 | 1.15 | - | 0.4 | - |
Long-Term Unearned Revenue | 11.74 | 14.97 | 17.93 | 20.73 | 23.77 |
Long-Term Deferred Tax Liabilities | 3.7 | 4.18 | 4.59 | 4.34 | 3.74 |
Other Long-Term Liabilities | 0.06 | 0.21 | 0.72 | 1.29 | 0.58 |
Total Liabilities | 256.47 | 262.8 | 311.23 | 310.2 | 231.83 |
Common Stock | 577.21 | 577.21 | 577.21 | 577.21 | 577.21 |
Additional Paid-In Capital | - | - | - | - | 2.35 |
Retained Earnings | 146.61 | 120.16 | 228.06 | 169.29 | 241.16 |
Total Common Equity | 723.82 | 697.37 | 805.27 | 746.5 | 820.72 |
Minority Interest | -2.92 | 25.57 | 28.21 | 43.29 | 108.55 |
Shareholders' Equity | 720.9 | 722.93 | 833.48 | 789.79 | 929.26 |
Total Liabilities & Equity | 977.37 | 985.73 | 1,145 | 1,100 | 1,161 |
Total Debt | 1.15 | 2.18 | 0.4 | 1.41 | - |
Net Cash (Debt) | 393.25 | 342.6 | 400.7 | 276.88 | 326.84 |
Net Cash Growth | 14.79% | -14.50% | 44.72% | -15.29% | 6.96% |
Net Cash Per Share | 0.70 | 0.56 | 0.68 | 0.49 | 0.56 |
Filing Date Shares Outstanding | 577.21 | 577.21 | 577.21 | 577.21 | 577.21 |
Total Common Shares Outstanding | 577.21 | 577.21 | 577.21 | 577.21 | 577.21 |
Working Capital | 326.04 | 300.83 | 385.01 | 315.76 | 416.82 |
Book Value Per Share | 1.25 | 1.21 | 1.40 | 1.29 | 1.42 |
Tangible Book Value | 656.97 | 629.3 | 735.92 | 677.96 | 733.41 |
Tangible Book Value Per Share | 1.14 | 1.09 | 1.27 | 1.17 | 1.27 |
Buildings | 411.09 | 411.09 | 411.09 | 410.52 | 435.5 |
Machinery | 219.04 | 222.35 | 223.41 | 219.51 | 226.5 |
Construction In Progress | - | - | - | 1.58 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.